Management of chronic insomnia disorder in adults: A clinical practice guideline from the American college of physicians

Clinical Guidelines Committee of the American College of Physicians

Research output: Contribution to journalArticle

Abstract

Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of chronic insomnia disorder in adults. Methods: This guideline is based on a systematic review of randomized, controlled trials published in English from 2004 through September 2015. Evaluated outcomes included global outcomes assessed by questionnaires, patient-reported sleep outcomes, and harms. The target audience for this guideline includes all clinicians, and the target patient population includes adults with chronic insomnia disorder. This guideline grades the evidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Recommendation 1: ACP recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for chronic insomnia disorder. (Grade: strong recommendation, moderate-quality evidence) Recommendation 2: ACP recommends that clinicians use a shared decision-making approach, including a discussion of the benefits, harms, and costs of short-term use of medications, to decide whether to add pharmacological therapy in adults with chronic insomnia disorder in whom cognitive behavioral therapy for insomnia (CBT-I) alone was unsuccessful. (Grade: weak recommendation, low-quality evidence)

Original languageEnglish (US)
Pages (from-to)125-133
Number of pages9
JournalAnnals of Internal Medicine
Volume165
Issue number2
DOIs
StatePublished - Jul 19 2016

Fingerprint

Sleep Initiation and Maintenance Disorders
Practice Guidelines
Physicians
Guidelines
Cognitive Therapy
Health Services Needs and Demand
Cost-Benefit Analysis
Decision Making
Sleep
Randomized Controlled Trials
Pharmacology

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Management of chronic insomnia disorder in adults : A clinical practice guideline from the American college of physicians. / Clinical Guidelines Committee of the American College of Physicians.

In: Annals of Internal Medicine, Vol. 165, No. 2, 19.07.2016, p. 125-133.

Research output: Contribution to journalArticle

Clinical Guidelines Committee of the American College of Physicians. / Management of chronic insomnia disorder in adults : A clinical practice guideline from the American college of physicians. In: Annals of Internal Medicine. 2016 ; Vol. 165, No. 2. pp. 125-133.
@article{932fefee33b24559a7ff8036cbbd5059,
title = "Management of chronic insomnia disorder in adults: A clinical practice guideline from the American college of physicians",
abstract = "Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of chronic insomnia disorder in adults. Methods: This guideline is based on a systematic review of randomized, controlled trials published in English from 2004 through September 2015. Evaluated outcomes included global outcomes assessed by questionnaires, patient-reported sleep outcomes, and harms. The target audience for this guideline includes all clinicians, and the target patient population includes adults with chronic insomnia disorder. This guideline grades the evidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Recommendation 1: ACP recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for chronic insomnia disorder. (Grade: strong recommendation, moderate-quality evidence) Recommendation 2: ACP recommends that clinicians use a shared decision-making approach, including a discussion of the benefits, harms, and costs of short-term use of medications, to decide whether to add pharmacological therapy in adults with chronic insomnia disorder in whom cognitive behavioral therapy for insomnia (CBT-I) alone was unsuccessful. (Grade: weak recommendation, low-quality evidence)",
author = "{Clinical Guidelines Committee of the American College of Physicians} and Amir Qaseem and Devan Kansagara and Forciea, {Mary Ann} and Molly Cooke and Denberg, {Thomas D.} and Barry, {Michael J.} and Cynthia Boyd and Chow, {R. Dobbin} and Nick Fitterman and Harris, {Russell P.} and Humphrey, {Linda L.} and Scott Manaker and Robert McLean and Mir, {Tanveer P.} and Sch{\"u}nemann, {Holger J.} and Sandeep Vijan and Timothy Wilt",
year = "2016",
month = "7",
day = "19",
doi = "10.7326/M15-2175",
language = "English (US)",
volume = "165",
pages = "125--133",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "2",

}

TY - JOUR

T1 - Management of chronic insomnia disorder in adults

T2 - A clinical practice guideline from the American college of physicians

AU - Clinical Guidelines Committee of the American College of Physicians

AU - Qaseem, Amir

AU - Kansagara, Devan

AU - Forciea, Mary Ann

AU - Cooke, Molly

AU - Denberg, Thomas D.

AU - Barry, Michael J.

AU - Boyd, Cynthia

AU - Chow, R. Dobbin

AU - Fitterman, Nick

AU - Harris, Russell P.

AU - Humphrey, Linda L.

AU - Manaker, Scott

AU - McLean, Robert

AU - Mir, Tanveer P.

AU - Schünemann, Holger J.

AU - Vijan, Sandeep

AU - Wilt, Timothy

PY - 2016/7/19

Y1 - 2016/7/19

N2 - Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of chronic insomnia disorder in adults. Methods: This guideline is based on a systematic review of randomized, controlled trials published in English from 2004 through September 2015. Evaluated outcomes included global outcomes assessed by questionnaires, patient-reported sleep outcomes, and harms. The target audience for this guideline includes all clinicians, and the target patient population includes adults with chronic insomnia disorder. This guideline grades the evidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Recommendation 1: ACP recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for chronic insomnia disorder. (Grade: strong recommendation, moderate-quality evidence) Recommendation 2: ACP recommends that clinicians use a shared decision-making approach, including a discussion of the benefits, harms, and costs of short-term use of medications, to decide whether to add pharmacological therapy in adults with chronic insomnia disorder in whom cognitive behavioral therapy for insomnia (CBT-I) alone was unsuccessful. (Grade: weak recommendation, low-quality evidence)

AB - Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of chronic insomnia disorder in adults. Methods: This guideline is based on a systematic review of randomized, controlled trials published in English from 2004 through September 2015. Evaluated outcomes included global outcomes assessed by questionnaires, patient-reported sleep outcomes, and harms. The target audience for this guideline includes all clinicians, and the target patient population includes adults with chronic insomnia disorder. This guideline grades the evidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Recommendation 1: ACP recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for chronic insomnia disorder. (Grade: strong recommendation, moderate-quality evidence) Recommendation 2: ACP recommends that clinicians use a shared decision-making approach, including a discussion of the benefits, harms, and costs of short-term use of medications, to decide whether to add pharmacological therapy in adults with chronic insomnia disorder in whom cognitive behavioral therapy for insomnia (CBT-I) alone was unsuccessful. (Grade: weak recommendation, low-quality evidence)

UR - http://www.scopus.com/inward/record.url?scp=84979641049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979641049&partnerID=8YFLogxK

U2 - 10.7326/M15-2175

DO - 10.7326/M15-2175

M3 - Article

C2 - 27136449

AN - SCOPUS:84979641049

VL - 165

SP - 125

EP - 133

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 2

ER -